Comparable Results Seen for HoLEP With, Without Preservation of Urethral Mucosa in BPH
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 5, 2024 -- For patients with benign prostatic hyperplasia (BPH), holmium laser enucleation of the prostate (HoLEP) with preservation of the urethral mucosa from bladder neck to the tip of the prostate has comparable efficacy and safety as HoLEP without retaining the urethral mucosa, according to a study published in the Nov. 15 issue of Medicine.
Lei Qiu, from the Affiliated Hospital 2 of Nantong University in China, and colleagues conducted a retrospective study of 208 patients with BPH to compare outcomes for HoLEP with and without preservation of the urethral mucosa from the bladder neck to the tip of the prostate for treatment of BPH (observation and control groups, respectively).
The researchers found that both groups of patients experienced an increase in maximum flow rate and a decrease in residual urine volume after the procedure. The immediate postoperative urinary continence rate was higher in the observation group versus the control group (98.23 versus 85.26 percent). Both groups of patients exhibited a significant increase in International Index of Erectile Function-5 scores after the procedure. In both groups of patients, there was a decrease seen in the occurrence rate of retrograde ejaculation after the procedure, with a lower score in the observation group. Both groups of patients had decreases in the International Prostate Symptom Score and quality of life scores after the procedure versus before the procedure.
"Preserving the longitudinal urethral mucosal segment from the bladder neck to the apex of the prostate during HoLEP treatment can improve instantaneous urinary control rate and reduce retrograde ejaculation rate," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.